Shiraishi K, Okita K, Kusano N, Harada T, Kondoh S, Okita S, Ryozawa S, Ohmura R, Noguchi T, Iida Y, Akiyama T, Oga A, Fukumoto Y, Furuya T, Kawauchi S, Sasaki K
Department of Pathology, Yamaguchi University School of Medicine, Yamaguchi, Japan.
Oncology. 2001;60(2):151-61. doi: 10.1159/000055313.
Tumors arising from the liver, biliary tract and pancreas, which originate in the foregut and are in close anatomical proximity to each other, sometimes show similar histological features. No studies have focused on genetic similarities and differences between tumors of these organs. To elucidate the similarities and differences in DNA copy number alterations between tumors of these organs, we applied comparative genomic hybridization (CGH) to cancers of the liver (31 cases), biliary tract (42 cases) and pancreas (27 cases). Some alterations were common to tumors of all three organs, and some were preferential in certain types of tumor. Gains of 1q and 8q and losses of 8p and 17p were common to all tumors. In contrast, 13q14 and 16q losses were detected exclusively in hepatocellular carcinomas (HCCs; p < 0.01). The incidence of 17q21 gain and 5q loss was higher in biliary tract cancers than in the other two types (p < 0.05). Pancreatic cancers exhibited higher incidence of 5q14-q23 gain and 19p loss than tumors of other organs (p < 0.01). Gains of 7p, 7q, 12p and 20q and losses of 3p, 6q, 9p and 18q were frequent in both biliary tract and pancreatic cancers but rare in HCCs (p < 0.05). The present results suggest that although genes located at 1q, 8p, 8q and 17p are frequently involved in HCC, biliary tract and pancreatic cancer, at least some of the genes implicated in carcinogenesis are different between these three types. It is also suggested that CGH analysis is useful as a potential adjunct for the diagnosis and management of these tumors of organs that are anatomically close to one another.
起源于前肠且在解剖位置上彼此相邻的肝脏、胆道和胰腺肿瘤,有时会表现出相似的组织学特征。尚无研究聚焦于这些器官肿瘤之间的基因异同。为阐明这些器官肿瘤在DNA拷贝数改变方面的异同,我们对31例肝癌、42例胆管癌和27例胰腺癌进行了比较基因组杂交(CGH)检测。部分改变在所有三个器官的肿瘤中都很常见,而有些则在特定类型的肿瘤中更为多见。1q和8q的扩增以及8p和17p的缺失在所有肿瘤中都很常见。相比之下,13q14和16q的缺失仅在肝细胞癌(HCC)中检测到(p < 0.01)。17q21扩增和5q缺失在胆管癌中的发生率高于其他两种类型(p < 0.05)。胰腺癌中5q14 - q23扩增和19p缺失的发生率高于其他器官的肿瘤(p < 0.01)。7p、7q、12p和20q的扩增以及3p、6q、9p和18q的缺失在胆管癌和胰腺癌中都很常见,但在HCC中很少见(p < 0.05)。目前的结果表明,尽管位于1q、8p、8q和17p的基因经常参与HCC、胆管癌和胰腺癌的发生,但这三种类型之间至少有一些与致癌作用相关的基因是不同的。这也表明CGH分析作为一种潜在的辅助手段,对于诊断和管理这些解剖位置相邻器官的肿瘤是有用的。